Editor's Note The Centers for Disease Control and Prevention on May 1 updated its weekly surveillance summary of COVID-19 activity in the US ending April 25. Among the updates: The percentage of specimens testing positive for SARS-CoV-2 decreased at public health and commercial laboratories and remained similar at clinical labs.…

Read More

Editor's Note In this randomized, double-blind, placebo-controlled, multicenter trial of remdesivir for the treatment of COVID-19, remdesivir was not associated with statistically significant clinical benefits. For the analysis, 237 patients were randomly assigned to either a treatment group with remdesivir (158 patients) or placebo (79 patients). Remdesivir use was not…

Read More

Editor's Note Abbott’s new COVID-19 antibody test that has 99% sensitivity and specificity has been given CE Mark approval for use across Europe, the April 29 Mass Device reports. The test is 99% accurate in identifying the IgG protein in patients infected by COVID-19, 14 days after symptoms develop. Abbott…

Read More

Editor's Note In this proof-of-concept study, a new lateral flow immunoassay developed by researchers from China can quickly detect antibodies against SARS-COV-2, which appear as a bright orange line when placed on a fluorescence reader. The test, which is based on a technique similar to what is used in home…

Read More

Editor's Note The spread of COVID-19 in the US could result in hundreds of billions of dollars in direct medical costs, according to this study partially funded by the Agency for Healthcare Research and Quality (AHRQ). Using AHRQ data and other sources, researchers developed computer models to simulate the financial…

Read More

Editor's Note The Occupational Safety and Health Administration (OSHA) on April 24 issued interim guidance on the reuse and decontamination of N95 and other filtering-facepiece respirators during the COVID-19 pandemic. OSHA notes that the National Institute for Occupational Safety and Health (NIOSH) has identified research that suggests the following methods…

Read More

Editor's Note An artificial intelligence (AI) tool that analyzes CT scans of the chest was 75% accurate in determining COVID-19 patients who required ventilators, the April Radiology Business reports. Researchers at Cleveland’s Case Western Reserve University built the tool using scans and datasets from the web, COVID-19 chest images from…

Read More

Editor's Note: Epic’s deterioration index, an artificial intelligence (AI), machine learning-based system that can predict which patients with COVID-19 could become seriously ill, has been put into use at hospitals nationwide, the April 24 STAT reports. Though normally hospitals would take weeks or months to test a new tool on…

Read More

Editor's Note COVID-19 may predispose patients to venous and arterial thrombotic disease because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis, this study finds. Though a recent document from the Centers for Disease Control and Prevention indicates an increased risk of severe COVID-19 in patients receiving antiplatelet agents and…

Read More

Editor's Note The Joint Commission on April 23 announced that it supports the Centers for Disease Control and Prevention’s new recommendations that healthcare facilities “. . . implement source control for everyone entering a healthcare facility (eg, healthcare personnel, patients, visitors), regardless of symptoms . . .” Source control involves…

Read More